Cargando…

Quality of life in patients with neurofibromatosis type 1 and 2 in Canada

BACKGROUND: There is scarce data on the quality of life of people with neurofibromatosis type 1 (NF1) and type 2 (NF2) in Canada. METHODS: A cross-sectional study of adults with NF1 and NF2 attending a tertiary center. Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain interferenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamoy-Jimenez, Geohana, Kim, Raymond, Suppiah, Suganth, Zadeh, Gelareh, Bril, Vera, Barnett, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317053/ https://www.ncbi.nlm.nih.gov/pubmed/32642740 http://dx.doi.org/10.1093/noajnl/vdaa003

Ejemplares similares

Special issue: a contemporary landscape of the clinical and biological research in neurofibromatosis type 1
por: Suppiah, Suganth, et al.
Publicado: (2020)

A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1
por: Hamoy-Jimenez, G., et al.
Publicado: (2022)

Multiplatform molecular analysis of vestibular schwannoma reveals two robust subgroups with distinct microenvironment
por: Landry, Alexander P., et al.
Publicado: (2023)

MULTIPLATFORM MOLECULAR ANALYSIS OF VESTIBULAR SCHWANNOMA REVEALS TWO ROBUST SUBGROUPS WITH DISTINCT MICROENVIRONMENT
por: Landry, Alexander P, et al.
Publicado: (2023)

SHH PATHWAY ACTIVATION DRIVES MALIGNANT TRANSFORMATION IN A SUBSET OF MPNSTS AND IS A POTENTIAL THERAPEUTIC TARGET
por: Suppiah, Suganth, et al.
Publicado: (2023)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Abdominal neoplastic manifestations of neurofibromatosis type 1
por: Dare, Anna J, et al.
Publicado: (2020)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020)

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life
por: Jones, Jennifer L, et al.
Publicado: (2019)

Extended Endoscopic Approach for Resection of Craniopharyngiomas
por: Almeida, João Paulo, et al.
Publicado: (2018)

Dendritic cell vaccines for high-grade gliomas
por: Eagles, Matthew E, et al.
Publicado: (2018)

Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
por: Velásquez, Carlos, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
por: Graff, Lesley A, et al.
Publicado: (2021)

Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
por: Galldiks, Norbert, et al.
Publicado: (2021)

Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations
por: de Blank, Peter, et al.
Publicado: (2020)

ECOA-8. Lung adenocarcinoma brain metastasis prediction using tumor DNA methylation profiling
por: Zuccato, Jeffrey, et al.
Publicado: (2021)

Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)

Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
por: Barnett, Carolina, et al.
Publicado: (2022)

The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis
por: Wei, Cheng-Jiang, et al.
Publicado: (2019)

The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019)

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus
por: Billings, Liana K., et al.
Publicado: (2018)

Executive functions and quality of life in children with neurofibromatosis type 1
por: Roy, Arnaud, et al.
Publicado: (2021)

Special issue: advances in the multimodality management of brain metastases and ongoing approaches to further improve their treatment
por: Zuccato, Jeffrey A, et al.
Publicado: (2021)

BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
por: Mansouri, Alireza, et al.
Publicado: (2022)

Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
por: Lee, Tin-Suet Joan, et al.
Publicado: (2023)

How to live with a meningioma: experiences, symptoms, and challenges reported by patients
por: Nassiri, Farshad, et al.
Publicado: (2020)

Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor
por: Fasih, Samir, et al.
Publicado: (2021)

Higher Global Diet Quality Score Is Inversely Associated with Risk of Type 2 Diabetes in US Women
por: Fung, Teresa T, et al.
Publicado: (2021)

71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES
por: Mamatjan, Yasin, et al.
Publicado: (2020)

Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life
por: Taylor, Lawrence A., et al.
Publicado: (2019)

Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD
por: Becker, Andreas, et al.
Publicado: (2011)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
por: Rose, Keeley L, et al.
Publicado: (2019)

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2
por: Ferner, Rosalie E., et al.
Publicado: (2014)

MMAP-09 CHARACTERISTICS CORRELATING WITH SURVIVAL IN PATIENTS TREATED FOR LARGE BRAIN METASTASES
por: Gutierrez-Valencia, Enrique, et al.
Publicado: (2022)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
por: Ellen Kuenzig, M, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo23cni5tjdog6gd1o8f8lcqe0